Clinical Trials for Renal Cell Carcinoma

Find clinical trials for renal cell carcinoma. Discover research opportunities and treatment options in your area.

126 Active Trials Found

Showing 126 trials on this page

Page 4 of 7

A Study of Oral 7HP349 (Alintegimod) in Combination with Ipilimumab Followed by Nivolumab Monotherapy

NCT ID: NCT06362369

This clinical trial is testing a new medication called Alintegimod, taken by mouth, in combination with two other treatments for patients with advanced cancers, such as melanoma, kidney cancer, and...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Lebanon, New Hampshire, United States +1 more

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

NCT ID: NCT06234605

This clinical trial is studying a new treatment combination of HC-7366 and belzutifan (also known as WELIREG™) for patients with a type of kidney cancer called renal cell carcinoma (RCC). Specifica...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States, Los Angeles, California, United States +13 more

PET/MR for Characterization of Renal Masses (RMs)

NCT ID: NCT06076538

This clinical trial is studying a new imaging technique called PET/MR to help doctors better understand different types of kidney tumors. Many kidney tumors are found by accident during scans for o...

Recruiting

Type: observational Locations: Dallas, Texas, United States, Dallas, Texas, United States

The Pharmacological Effects of Using Cabozantinib With a Light Breakfast

NCT ID: NCT05263245

This clinical trial is studying how taking the cancer medication cabozantinib with a light breakfast might affect its effectiveness and side effects for patients with advanced kidney cancer. Typica...

Recruiting

Phase: PHASE2 Type: interventional Locations: Leiden, Zuid Holland, Netherlands, Rotterdam, Zuid Holland, Netherlands

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

NCT ID: NCT04787042

This clinical trial is investigating a new treatment called ST-067 for various types of advanced cancer, including melanoma, renal cell carcinoma, and triple-negative breast cancer. The study is di...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Buffalo, New York, United States +5 more

Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell Carcinoma

NCT ID: NCT05188118

This clinical trial is designed to test a new treatment approach for patients with a type of kidney cancer called metastatic or unresectable clear cell renal cell carcinoma. In this study, 20 parti...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: New York, New York, United States

[18F]PT2385 PET/CT in Patients with Renal Cell Carcinoma

NCT ID: NCT04989959

This clinical trial is exploring a new imaging technique called [18F]PT2385 Positron Emission Tomography/Computed Tomography (PET/CT) to better understand a protein called HIF2α in patients with re...

Recruiting

Phase: PHASE1 Type: interventional Locations: Dallas, Texas, United States

Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study

NCT ID: NCT05810571

This clinical trial is studying two different methods to manage pain after a specific type of surgery called open nephrectomy, which is performed to remove a kidney due to renal cell carcinoma. The...

Recruiting

Phase: NA Type: interventional Locations: Kocaeli, , Turkey, Kocaeli, , Turkey +1 more

Anti-CD70-CAR-T Cell Injection for the Treatment of Locally Advanced or Relapsed/Metastatic CD70+ Inoperable Renal Cells

NCT ID: NCT06586658

This clinical trial is testing a new treatment called anti-CD70-CAR T-cell therapy for patients with advanced or recurrent kidney cancer that cannot be surgically removed. The goal is to see if thi...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

Safety and Efficacy of NEO212 in Patients with Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

NCT ID: NCT06047379

This clinical trial is exploring a new treatment called NEO212 for patients with specific types of brain tumors, including Astrocytoma IDH-mutant and Glioblastoma IDH-wildtype, as well as other sol...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tacoma, Washington, United States, Beverly Hills, California, United States

TFE Renal Cell Carcinoma: A Prospective Registry and Translational Research Initiative

NCT ID: NCT03630536

This clinical trial is focused on a specific type of kidney cancer called TFE Renal Cell Carcinoma (TFE RCC). The goal of the study is to gather important information about this rare cancer, includ...

Recruiting

Type: observational Locations: Cincinnati, Ohio, United States

Registry Platform Urologic Cancer

NCT ID: NCT03374267

This clinical trial, called the Registry Platform Urologic Cancer, is focused on understanding and collecting important information about patients with advanced renal cell carcinoma (a type of kidn...

Recruiting

Type: observational Locations: Multiple Locations, , Germany

GI-101 As a Single Agent or in Combination with Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors

NCT ID: NCT04977453

This clinical trial is studying a new treatment called GI-101, which may be used alone or alongside other therapies like pembrolizumab, lenvatinib, or local radiotherapy. The main goal is to assess...

Recruiting

Phase: PHASE1 Type: interventional Locations: Huntersville, North Carolina, United States, Seoul, , Korea, Republic Of +7 more

Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma

NCT ID: NCT04669860

This clinical trial is studying the types of bacteria and fungi that may be linked to two conditions: calcium oxalate urolithiasis (which means having kidney stones made of calcium oxalate) and ren...

Recruiting

Type: observational Locations: Miami, Florida, United States

A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma

NCT ID: NCT06585878

This clinical trial is studying a treatment called Stereotactic Ablative Radiotherapy (SABR) for patients with a specific type of kidney cancer known as oligometastatic renal cell carcinoma, which ...

Not yet recruiting

Phase: NA Type: interventional

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

NCT ID: NCT06582017

This clinical trial, titled QXL138AM-001, is looking at a new treatment called QXL138AM for patients with certain types of advanced cancers, such as ovarian, pancreatic, and lung cancer, as well as...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Atlanta, Georgia, United States +6 more

Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients

NCT ID: NCT06577961

This clinical trial is looking at a new treatment for patients with advanced kidney cancer, specifically a type called renal cell carcinoma (RCC) that has not been treated before. The study will te...

Not yet recruiting

Phase: PHASE1 Type: interventional

A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

NCT ID: NCT01890590

This clinical trial is exploring a treatment called CyberKnife Radiosurgery for patients with a specific type of kidney cancer known as renal cell carcinoma. This technology allows doctors to deliv...

Recruiting

Phase: NA Type: interventional Locations: Boston, Massachusetts, United States

PRO1160 for Advanced Solid and Liquid Tumors (PRO1160-001)

NCT ID: NCT05721222

This clinical trial, called PRO1160-001, is researching a new drug named PRO1160 for patients with advanced solid tumors or certain types of blood cancers, specifically Renal Cell Carcinoma (a type...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ann Arbor, Michigan, United States, Portland, Oregon, United States +33 more

Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy

NCT ID: NCT06523049

This clinical trial is studying a combination of two medications, Vorolanib and Sintilimab, to see if they can help people with advanced renal cell carcinoma (a type of kidney cancer) who have not ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Chengdu, Sichuan, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions